Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

63.35
+2.584.25%
Post-market: 62.50-0.8500-1.34%19:58 EST
Volume:1.58M
Turnover:99.26M
Market Cap:7.75B
PE:-10.03
High:63.80
Open:60.99
Low:60.45
Close:60.77
52wk High:69.33
52wk Low:29.31
Shares:122.26M
Float Shares:119.09M
Volume Ratio:0.94
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.3179
EPS(LYR):-5.2646
ROE:-572.15%
ROA:-24.93%
PB:-14.86
PE(LYR):-12.03

Loading ...

Director Edward M. Kaye Reports Disposal of Cytokinetics Incorporated Common Shares

Reuters
·
Nov 13

Sector Update: Health Care Stocks Climb Tuesday Afternoon

MT Newswires Live
·
Nov 12

Stock Track | Cytokinetics Soars 5% on Positive Aficamten Outlook and RBC's Raised Price Target

Stock Track
·
Nov 12

Cytokinetics' 2026 Aficamten Launch Could Gain From Differentiated Strategy, RBC Says

MT Newswires Live
·
Nov 12

Cytokinetics Is Maintained at Outperform by RBC Capital

Dow Jones
·
Nov 11

Investors File Class Action Against Cytokinetics Over Securities Fraud Allegations

Reuters
·
Nov 11

B. Riley Adjusts Price Target on Cytokinetics to $90 From $80, Maintains Buy Rating

MT Newswires Live
·
Nov 10

Cytokinetics Reports Aficamten Outperforms Metoprolol in HCM Exercise Capacity Trial

Reuters
·
Nov 10

Cytokinetics Presents Additional Data From Maple-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025

THOMSON REUTERS
·
Nov 10

Cytokinetics (CYTK) Gets a Buy from Evercore ISI

TIPRANKS
·
Nov 06

Strategic Positioning and Launch Readiness Propel Cytokinetics to ‘Buy’ Rating

TIPRANKS
·
Nov 06

Earnings Flash (CYTK) Cytokinetics Posts Q3 Loss $2.55 vs. FactSet Est of $1.57 Loss

MT Newswires Live
·
Nov 06

Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens

Reuters
·
Nov 06

Cytokinetics Q3 EPS $(2.25) Misses $(1.57) Estimate, Sales $1.936M Miss $3.556M Estimate

Benzinga
·
Nov 06

BRIEF-Cytokinetics Q3 Basic EPS USD -2.55

Reuters
·
Nov 06

Cytokinetics Reports Q3 Revenue of $1.9 Million

Reuters
·
Nov 06

Cytokinetics Q3 Net Income USD -306.178 Million

THOMSON REUTERS
·
Nov 06

Cytokinetics Faces Investor Class Action Over Securities Fraud Allegations

Reuters
·
Nov 06

Cytokinetics EVP Research & Development Fady Ibraham Malik Reports Disposal of Common Shares

Reuters
·
Nov 05

Cytokinetics to Participate in November Investor Conferences

GlobeNewswire
·
Nov 05